Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Provectus announces encouraging results for cancer drug
Peter Hersey, an oncologist and authority on melanoma, said that treatment of one of the tumors with PV-10 led to complete eradication of all four tumors that had
Peter Hersey, an oncologist and authority on melanoma, said that treatment of one of the tumors with PV-10 led to complete eradication of all four tumors that had
The US supply chain is part of Roche’s global production network, which will be capable of producing 400 million treatment courses of Tamiflu annually by the end of
Swiss biotechnology company Mondobiotech will receive a $7.5 million upfront payment and up to $30 million in milestones payments for successful development and commercialization of Aviptadil in PAH
The previously announced phase II randomized study will compare AZD6244 to temozolomide in the treatment of stage III / IV melanoma patients. AstraZeneca expects to enroll up to
During the one-year study, patients using Exenatide showed improvements in three important measures of blood glucose control: fasting blood glucose, postprandial blood glucose, and hemoglobin A1C (HbA1C). Exenatide
Januvia is an investigational once-daily medicine that, if approved, would potentially be the first in a new class of oral drugs in the US that enhance the body's
Galvus showed a 1.8% reduction in blood sugar levels, comparable to Avandia, but without weight gain overall and with a lower incidence of edema (fluid retention) – both
While passive smoke exposure could result in decreased absorption, Exubera could be used by patients who were exposed to a smoky environment, the company said. The treatment can
Rhodia initiated an arbitration procedure in 2005 seeking E570 million from Sanofi-Aventis in order to meet environmental and pension costs. The costs were inherited when it was spun
Takeda said that study data shows that Actos can have a positive effect on several measures of cardiovascular disease outcomes in high-risk patients with type two diabetes. In